ITMCTR2000003084Not yet recruitingPhase 4
Real World Study of Ningmitai Capsule in Treating Chronic Prostatitis Symptoms
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational study
Eligibility Criteria
- Sex
- Male
Inclusion Criteria
- •1. Chronic prostatitis: Chronic and recurrent pelvic discomfort or pain (NIH-CPSI pain score >= 4) lasting more than 3 months;
- •2. The patients accepted urine routine, EPS routine and prostate color ultrasound examination and were willing to follow-up on time;
- •3. According to the 2014 edition of the China Society of Urology's guidelines for the diagnosis and treatment of chronic prostatitis, treatment options are determined by doctors The use of proprietary Chinese medicine according to the Chinese Society of Integrated Traditional Chinese and Western medicine andrology 2015 edition of chronic prostatitis integrated traditional Chinese and Western medicine expert consensus using Ningbitai capsules;
- •4. Volunteer and agree to sign an informed consent.
Exclusion Criteria
- •1. Patients who were involved in other clinical studies;
- •2. Urine routine or color doppler ultrasound examination of the prostate suggested other organic diseases of the Urinary System;
- •3. Patients with serious cardiovascular, cerebrovascular, liver, Kidney, hematopoiesis and psychosis;
- •4. People who are known to be allergic to Ningmitai capsules or some of their ingredients.
Investigators
Similar Trials
Recruiting
Phase 4
Real world research for Pingxiao capsule to treat triple negative breast cancer researchBreast cancerITMCTR2100004629The First Affiliated Hospital of Xi'an Jiaotong University
Not yet recruiting
Phase 4
Clinical Observation of Shengui Capsule Intervention in Heart Failure with Preserved Ejection Fractioheart failure with preserved ejection fractionITMCTR2200005794Dongzhimen Hospital, Beijing University of Chinese Medicine
Recruiting
Phase 1
Real world clinical study of Liushen capsule in the treatment of pharyngitis and tonsillitispharyngitis, amygdalitisITMCTR2100004400The First Tianjin Medical University General Hospital, Affiliated Hospital of Guangzhou University of traditional Chinese Medicine
Not yet recruiting
Not Applicable
Prospective clinical study of Jintiange capsule in the treatment of osteosarcopeniasarcopenia and osteoporosisITMCTR2200006637The Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Recruiting
Phase 4
A randomized controlled trial of Naoxintong Capsule to reduce major cardiovascular adverse events (MACE) in patients with acute coronary syndrome (ACS)Acute coronary syndromeITMCTR2000003509The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine